Ischemic heart disease (IHD) remains a major cause of morbidity and mortality in Iran, but evidence is dispersed across model‐based estimates, population studies, registries, hospital surveillance, and death‐registration data. We synthesized national and subnational evidence on IHD burden in Iran from 1990 to 2023.
Mehrdad Rabiee Rad, B. Darouei, Ghazal Ghasempour Dabaghi et al.· Clinical Cardiology· 0 citations
Background: Machine learning (ML) models are increasingly used to predict adverse outcomes after transcatheter aortic valve replacement (TAVR), but their generalizability and clinical readiness remain uncertain. We evaluated predictive performance across post-TAVR outcomes, emphasizing validation quality, transportabil...
A. Alizadehasl, Elahe Abdi Bastami, Seyedeh Fatemeh Hosseini Jebelli et al.· Journal of Clinical Medicine· 0 citations
The atherogenic index of plasma (AIP) is a lipid‐based indicator of cardiometabolic risk. We examined whether AIP is associated with prevalent type 2 diabetes mellitus (T2DM) and fasting blood sugar (FBS) in patients with premature coronary artery disease (PCAD) and explored whether this association differed across Ira...
Raza Amani-Beni, G. Dabaghi, N. Mohammadifard et al.· Endocrinology, Diabetes & Me...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.